Table: Hisamitsu -2017/18 parent results
Apr 10 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2018 Feb 28, 2017 Feb 28, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 112.39 112.67
(-0.2 pct) (-5.6 pct)
Operating 20.52 21.54
(-4.8 pct) (-16.1 pct)
Recurring 21.37 22.71
(-5.9 pct) (-13.6 pct)
Net 14.62 16.74
(-12.7 pct) (-1.1 pct)
EPS 174.70 yen 197.98 yen
EPS Diluted 174.57 yen 197.88 yen
Ann Div 82.00 yen 81.50 yen 82.50 yen
-Q2 Div 41.00 yen 40.50 yen 41.25 yen
-Q4 Div 41.00 yen 41.00 yen 41.25 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO